The p27–Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells

References

• Claman HN. Corticosteroids and lymphoid cells. N Engl J Med 1972; 287:388 - 97; http://dx.doi.org/10.1056/NEJM197208242870806; PMID: 5043524
   PubMed Web of Science ®Google Scholar
• Norman MR, Thompson EB. Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res 1977; 37:3785 - 91; PMID: 269011
   PubMed Web of Science ®Google Scholar
• Inaba H, Pui C-H. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 2010; 11:1096 - 106; http://dx.doi.org/10.1016/S1470-2045(10)70114-5; PMID: 20947430
   PubMed Web of Science ®Google Scholar
• Wright AP, Zilliacus J, McEwan IJ, Dahlman-Wright K, Almlöf T, Carlstedt-Duke J, et al. Structure and function of the glucocorticoid receptor. J Steroid Biochem Mol Biol 1993; 47:11 - 9; http://dx.doi.org/10.1016/0960-0760(93)90052-X; PMID: 8274424
   PubMed Web of Science ®Google Scholar
• Reichardt HM, Schütz G. Glucocorticoid signalling–multiple variations of a common theme. Mol Cel Endocrine 1998; 146:1 - 6; http://dx.doi.org/10.1016/S0303-7207(98)00208-1
   PubMed Web of Science ®Google Scholar
• Kassel O, Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 2007; 275:13 - 29; http://dx.doi.org/10.1016/j.mce.2007.07.003; PMID: 17689856
   PubMed Web of Science ®Google Scholar
• Ausserlechner MJ, Obexer P, Böck G, Geley S, Kofler R. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells. Cell Death Differ 2004; 11:165 - 74; http://dx.doi.org/10.1038/sj.cdd.4401328; PMID: 14576768
   PubMed Web of Science ®Google Scholar
• Harrison RW 3rd, Lippman SS, Hendry WJ 3rd, Chien MC. Isolation of a genomic sublibrary enriched for glucocorticoid-regulated genes. DNA Cell Biol 1990; 9:95 - 102; http://dx.doi.org/10.1089/dna.1990.9.95; PMID: 2344394
   PubMed Web of Science ®Google Scholar
• Smith JB, Herschman HR. Targeted identification of glucocorticoid-attenuated response genes: in vitro and in vivo models. Proc Am Thorac Soc 2004; 1:275 - 81; http://dx.doi.org/10.1513/pats.200402-017MS; PMID: 16113446
   PubMedGoogle Scholar
• Wang J-C, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, Yamamoto KR. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci USA 2004; 101:15603 - 8; http://dx.doi.org/10.1073/pnas.0407008101; PMID: 15501915
   PubMed Web of Science ®Google Scholar
• Obexer P, Certa U, Kofler R, Helmberg A. Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis. Oncogene 2001; 20:4324 - 36; http://dx.doi.org/10.1038/sj.onc.1204573; PMID: 11466613
   PubMed Web of Science ®Google Scholar
• Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmüller C, et al. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 2006; 107:2061 - 9; http://dx.doi.org/10.1182/blood-2005-07-2853; PMID: 16293608
   PubMed Web of Science ®Google Scholar
• Ploner C, Rainer J, Niederegger H, Eduardoff M, Villunger A, Geley S, et al. The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia. Leukemia 2008; 22:370 - 7; http://dx.doi.org/10.1038/sj.leu.2405039; PMID: 18046449
   PubMed Web of Science ®Google Scholar
• Baghdassarian N, Catallo R, Mahly MA, Ffrench P, Chizat F, Bryon PA, et al. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins. Exp Cell Res 1998; 240:263 - 73; http://dx.doi.org/10.1006/excr.1998.3942; PMID: 9596999
   PubMed Web of Science ®Google Scholar
• Baghdassarian N, Peiretti A, Devaux E, Bryon PA, Ffrench M. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes. Cell Growth Differ 1999; 10:405 - 12; PMID: 10392902
   PubMedGoogle Scholar
• Peiretti A, Baghdassarian N, Gerland LM, Ffrench P, Bryon PA, Magaud JP, et al. CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes. Eur J Cell Biol 2003; 82:253 - 61; http://dx.doi.org/10.1078/0171-9335-00298; PMID: 12800980
   PubMed Web of Science ®Google Scholar
• Rogatsky I, Trowbridge JM, Garabedian MJ. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol Cell Biol 1997; 17:3181 - 93; PMID: 9154817
   PubMed Web of Science ®Google Scholar
• Hengst L, Reed SI. Inhibitors of the Cip/Kip family. Curr Top Microbiol Immunol 1998; 227:25 - 41; http://dx.doi.org/10.1007/978-3-642-71941-7_2; PMID: 9479824
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501 - 12; http://dx.doi.org/10.1101/gad.13.12.1501; PMID: 10385618
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9:1149 - 63; http://dx.doi.org/10.1101/gad.9.10.1149; PMID: 7758941
   PubMed Web of Science ®Google Scholar
• Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 2008; 8:253 - 67; http://dx.doi.org/10.1038/nrc2347; PMID: 18354415
   PubMed Web of Science ®Google Scholar
• Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269:682 - 5; http://dx.doi.org/10.1126/science.7624798; PMID: 7624798
   PubMed Web of Science ®Google Scholar
• Sutterlüty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Müller U, et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1:207 - 14; http://dx.doi.org/10.1038/12027; PMID: 10559918
   PubMed Web of Science ®Google Scholar
• Kitagawa K, Kotake Y, Kitagawa M. Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci 2009; 100:1374 - 81; http://dx.doi.org/10.1111/j.1349-7006.2009.01196.x; PMID: 19459846
   PubMed Web of Science ®Google Scholar
• Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, et al. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 2004; 6:661 - 72; http://dx.doi.org/10.1016/S1534-5807(04)00131-5; PMID: 15130491
   PubMed Web of Science ®Google Scholar
• Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, Malek NP. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Genes Dev 2004; 18:2602 - 7; http://dx.doi.org/10.1101/gad.321004; PMID: 15520280
   PubMed Web of Science ®Google Scholar
• Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G, et al. Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci USA 2001; 98:2515 - 20; http://dx.doi.org/10.1073/pnas.041475098; PMID: 11226270
   PubMed Web of Science ®Google Scholar
• Hengst L, Reed SI. Translational control of p27Kip1 accumulation during the cell cycle. Science 1996; 271:1861 - 4; http://dx.doi.org/10.1126/science.271.5257.1861; PMID: 8596954
   PubMed Web of Science ®Google Scholar
• Zhang H, Kobayashi R, Galaktionov K, Beach D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 1995; 82:915 - 25; http://dx.doi.org/10.1016/0092-8674(95)90271-6; PMID: 7553852
   PubMed Web of Science ®Google Scholar
• Hengst L, Göpfert U, Lashuel HA, Reed SI. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). Genes Dev 1998; 12:3882 - 8; http://dx.doi.org/10.1101/gad.12.24.3882; PMID: 9869641
   PubMed Web of Science ®Google Scholar
• Evans RM. Molecular characterization of the glucocorticoid receptor. Recent Prog Horm Res 1989; 45:discussion 22–7 1 - 22, discussion 22-7; PMID: 2682841
   PubMedGoogle Scholar
• Beato M, Herrlich P, Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995; 83:851 - 7; http://dx.doi.org/10.1016/0092-8674(95)90201-5; PMID: 8521509
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83:835 - 9; http://dx.doi.org/10.1016/0092-8674(95)90199-X; PMID: 8521507
   PubMed Web of Science ®Google Scholar
• Scheidereit C, Westphal HM, Carlson C, Bosshard H, Beato M. Molecular model of the interaction between the glucocorticoid receptor and the regulatory elements of inducible genes. DNA 1986; 5:383 - 91; http://dx.doi.org/10.1089/dna.1986.5.383; PMID: 3096677
   PubMedGoogle Scholar
• Borriello A, Cucciolla V, Oliva A, Zappia V, Della Ragione F. p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle 2007; 6:1053 - 61; http://dx.doi.org/10.4161/cc.6.9.4142; PMID: 17426451
   PubMed Web of Science ®Google Scholar
• Kolluri SK, Weiss C, Koff A, Göttlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999; 13:1742 - 53; http://dx.doi.org/10.1101/gad.13.13.1742; PMID: 10398686
   PubMed Web of Science ®Google Scholar
• Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404:782 - 7; http://dx.doi.org/10.1038/35008115; PMID: 10783894
   PubMed Web of Science ®Google Scholar
• Ma J, Xie Y, Shi Y, Qin W, Zhao B, Jin Y. Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem Biophys Res Commun 2008; 377:894 - 8; http://dx.doi.org/10.1016/j.bbrc.2008.10.097; PMID: 18957280
   PubMed Web of Science ®Google Scholar
• Bretones G, Acosta JC, Caraballo JM, Ferrándiz N, Gómez-Casares MT, Albajar M, et al. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. J Biol Chem 2011; 286:9815 - 25; http://dx.doi.org/10.1074/jbc.M110.165977; PMID: 21245140
   PubMed Web of Science ®Google Scholar
• Yung Y, Walker JL, Roberts JM, Assoian RKA. A Skp2 autoinduction loop and restriction point control. J Cell Biol 2007; 178:741 - 7; http://dx.doi.org/10.1083/jcb.200703034; PMID: 17724117
   PubMed Web of Science ®Google Scholar
• Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, et al. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma. Cancer Res 2010; 70:3791 - 802; http://dx.doi.org/10.1158/0008-5472.CAN-09-1245; PMID: 20424123
   PubMed Web of Science ®Google Scholar
• Hershko DD. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Cancer 2008; 112:1415 - 24; http://dx.doi.org/10.1002/cncr.23317; PMID: 18260093
   PubMed Web of Science ®Google Scholar
• Chen Q, Xie W, Kuhn DJ, Voorhees PM, Lopez-Girona A, Mendy D, et al. Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy. Blood 2008; 111:4690 - 9; http://dx.doi.org/10.1182/blood-2007-09-112904; PMID: 18305219
   PubMed Web of Science ®Google Scholar
• Daniel V, Litwack G, Tomkins GM. Induction of cytolysis of cultured lymphoma cells by adenosine 3′:5′-cyclic monophosphate and the isolation of resistant variants. Proc Natl Acad Sci USA 1973; 70:76 - 9; http://dx.doi.org/10.1073/pnas.70.1.76; PMID: 4346041
   PubMed Web of Science ®Google Scholar
• Strasser-Wozak EM, Hattmannstorfer R, Hála M, Hartmann BL, Fiegl M, Geley S, et al. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res 1995; 55:348 - 53; PMID: 7812967
   PubMed Web of Science ®Google Scholar
• Schwartz O, Virelizier JL, Montagnier L, Hazan U. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene 1990; 88:197 - 205; http://dx.doi.org/10.1016/0378-1119(90)90032-M; PMID: 2189784
   PubMed Web of Science ®Google Scholar
• Ausserlechner MJ, Obexer P, Deutschmann A, Geiger K, Kofler R. A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes. Mol Cancer Ther 2006; 5:1927 - 34; http://dx.doi.org/10.1158/1535-7163.MCT-05-0500; PMID: 16928812
   PubMed Web of Science ®Google Scholar
• Jäkel H, Weinl C, Hengst L. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control. Oncogene 2011; 30:3502 - 12; http://dx.doi.org/10.1038/onc.2011.68; PMID: 21423214
   PubMed Web of Science ®Google Scholar
• Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB, et al. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007; 128:269 - 80; http://dx.doi.org/10.1016/j.cell.2006.11.047; PMID: 17254966
   PubMed Web of Science ®Google Scholar
• Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52:456 - 67; http://dx.doi.org/10.1016/0042-6822(73)90341-3; PMID: 4705382
   PubMed Web of Science ®Google Scholar
• Kwon TK, Nagel JE, Buchholz MA, Nordin AA. Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene 1996; 180:113 - 20; http://dx.doi.org/10.1016/S0378-1119(96)00416-7; PMID: 8973354
   PubMed Web of Science ®Google Scholar
• Aviv H, Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA 1972; 69:1408 - 12; http://dx.doi.org/10.1073/pnas.69.6.1408; PMID: 4504350
   PubMed Web of Science ®Google Scholar
• Kalejta RF, Brideau AD, Banfield BW, Beavis AJ. An integral membrane green fluorescent protein marker, Us9-GFP, is quantitatively retained in cells during propidium iodide-based cell cycle analysis by flow cytometry. Exp Cell Res 1999; 248:322 - 8; http://dx.doi.org/10.1006/excr.1999.4427; PMID: 10094838
   PubMed Web of Science ®Google Scholar
• Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, et al. RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis. J Biol Chem 1998; 273:14620 - 5; http://dx.doi.org/10.1074/jbc.273.23.14620; PMID: 9603979
   PubMed Web of Science ®Google Scholar